{ "labelLang" : "hun", "responseDate" : "2024-03-29 15:38", "content" : { "otype" : "BookChapter", "mtid" : 23547377, "status" : "APPROVED", "published" : true, "comment" : "Cited By :1 \n Export Date: 12 September 2022 \n Correspondence Address: Superti-Furga, A.; Department of Pediatrics, , Freiburg, Germany", "unhandledTickets" : 0, "oldTimestamp" : "2018-09-13T11:57:09.000+0000", "deleted" : false, "oldId" : 13547377, "lastRefresh" : "2022-12-21T12:14:00.004+0000", "lastModified" : "2021-06-24T11:08:02.113+0000", "created" : "2014-01-08T11:11:36.000+0000", "creator" : { "otype" : "Author", "mtid" : 10000030, "link" : "/api/author/10000030", "label" : "Váradi András (Biokémia)", "familyName" : "Váradi", "givenName" : "András", "published" : true, "oldId" : 10000030, "snippet" : true }, "lastDuplumSearch" : "2022-09-12T14:34:03.882+0000", "core" : false, "citation" : true, "publicationPending" : false, "type" : { "otype" : "PublicationType", "mtid" : 25, "link" : "/api/publicationtype/25", "label" : "Könyvrészlet", "code" : 25, "otypeName" : "BookChapter", "listPosition" : 2, "published" : true, "oldId" : 25, "snippet" : true }, "category" : { "otype" : "Category", "mtid" : 1, "link" : "/api/category/1", "label" : "Tudományos", "published" : true, "oldId" : 1, "snippet" : true }, "languages" : [ { "otype" : "Language", "mtid" : 10002, "link" : "/api/language/10002", "label" : "Angol", "name" : "Angol", "nameEng" : "English", "published" : true, "oldId" : 2, "snippet" : true } ], "firstAuthor" : "Superti-Furga, A", "authorships" : [ { "otype" : "PersonAuthorship", "mtid" : 31562810, "link" : "/api/authorship/31562810", "label" : "Superti-Furga, A", "listPosition" : 1, "share" : 0.0, "first" : true, "last" : false, "familyName" : "Superti-Furga", "givenName" : "A", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "oldId" : 50347059, "snippet" : true }, { "otype" : "PersonAuthorship", "mtid" : 31562811, "link" : "/api/authorship/31562811", "label" : "Unger, S", "listPosition" : 2, "share" : 0.0, "first" : false, "last" : true, "familyName" : "Unger", "givenName" : "S", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "oldId" : 50347058, "snippet" : true } ], "title" : "Prenatal Diagnosis of Disorders of Bone and Connective Tissue", "identifiers" : [ { "otype" : "PublicationIdentifier", "mtid" : 7027586, "link" : "/api/publicationidentifier/7027586", "label" : "DOI: 10.1002/9781444314342.ch22", "source" : { "otype" : "PlainSource", "mtid" : 6, "link" : "/api/publicationsource/6", "label" : "DOI", "type" : { "otype" : "PublicationSourceType", "mtid" : 10001, "link" : "/api/publicationsourcetype/10001", "label" : "DOI", "mayHaveOa" : true, "published" : true, "snippet" : true }, "name" : "DOI", "nameEng" : "DOI", "linkPattern" : "https://doi.org/@@@", "publiclyVisible" : true, "published" : true, "oldId" : 6, "snippet" : true }, "validState" : "IDENTICAL", "idValue" : "10.1002/9781444314342.ch22", "realUrl" : "https://doi.org/10.1002/9781444314342.ch22", "published" : false, "oldId" : 4700645, "snippet" : true }, { "otype" : "PublicationIdentifier", "mtid" : 7027585, "link" : "/api/publicationidentifier/7027585", "label" : "Scopus: 84882816692", "source" : { "otype" : "PlainSource", "mtid" : 3, "link" : "/api/publicationsource/3", "label" : "Scopus", "type" : { "otype" : "PublicationSourceType", "mtid" : 10003, "link" : "/api/publicationsourcetype/10003", "label" : "Indexelő adatbázis", "mayHaveOa" : false, "published" : true, "snippet" : true }, "name" : "Scopus", "linkPattern" : "http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-@@@", "publiclyVisible" : true, "published" : true, "oldId" : 3, "snippet" : true }, "validState" : "IDENTICAL", "idValue" : "84882816692", "realUrl" : "http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-84882816692", "published" : false, "oldId" : 4700644, "snippet" : true } ], "firstPage" : "680", "lastPage" : "704", "firstPageOrInternalIdForSort" : "680", "pageLength" : 25, "publishedYear" : 2010, "digital" : null, "printed" : null, "sourceYear" : 2014, "packet" : "457782", "foreignEdition" : true, "foreignLanguage" : true, "fullPublication" : false, "conferencePublication" : null, "nationalOrigin" : null, "missingAuthor" : false, "oaType" : "NONE", "oaCheckDate" : "2022-12-21", "oaFree" : false, "citationCount" : 0, "citationCountUnpublished" : 0, "citationCountWoOther" : 0, "independentCitCountWoOther" : 0, "doiCitationCount" : 0, "wosCitationCount" : 0, "scopusCitationCount" : 0, "independentCitationCount" : 0, "unhandledCitationCount" : 0, "citingPubCount" : 0, "independentCitingPubCount" : 0, "unhandledCitingPubCount" : 0, "citedPubCount" : 2, "citedCount" : 2, "referenceList" : "McKusick, V., Heritable disorders of connective tissue (1956), St Louis, MO: MosbyDugoff, L., Coffin, C.T., Hobbins, J.C., Sonographic measurement of the fetal rib cage perimeter to thoracic circumference ratio: application to prenatal diagnosis of skeletal dysplasias (1997) Ultrasound Obstet Gynecol, 10, p. 269; \n\nGaffney, G., Manning, N., Boyd, P.A., Prenatal sonographic diagnosis of skeletal dysplasias-a report of the diagnostic and prognostic accuracy in 35 cases (1998) Prenat Diagn, 18, p. 357; \n\nGoncalves, L., Jeanty, P., Fetal biometry of skeletal dysplasias: a multicentric study (1994) J Ultrasound Med, 13, p. 767; \n\nGrannum, P.A., Hobbins, J.C., Prenatal diagnosis of fetal skeletal dysplasias (1983) Semin Perinatol, 7, p. 125; \n\nKrakow, D., Williams, J., Poehl, M., Use of three-dimensional ultrasound imaging in the diagnosis of prenatal-onset skeletal dysplasias (2003) Ultrasound Obstet Gynecol, 21, p. 467; \n\nKurtz, A.B., Wapner, R.J., Ultrasonographic diagnosis of second-trimester skeletal dysplasias: a prospective analysis in a high-risk population (1983) J Ultrasound Med, 2, p. 99; \n\nRahemtullah, A., McGillivray, B., Wilson, R.D., Suspected skeletal dysplasias: femur length to abdominal circummutations ference ratio can be used in ultrasonographic prediction of fetal outcome (1997) Am J Obstet Gynecol, 177, p. 864; \n\nSharony, R., Browne, C., Lachman, R.S., Prenatal diagnosis of the skeletal dysplasias (1993) Am J Obstet Gynecol, 169, p. 668; \n\nSpirt, B.A., Oliphant, M., Gottlieb, R.H., Prenatal sonographic evaluation of short-limbed dwarfism: an algorithmic approach (1990) Radiographics, 10, p. 217; \n\nWitters, I., Moerman, P., Fryns, J.P., Skeletal dysplasias: 38 prenatal cases (2008) Genet Couns, 19, p. 267; \n\nDighe, M., Fligner, C., Cheng, E., Fetal skeletal dysplasia: an approach to diagnosis with illustrative cases (2008) Radiographics, 28, p. 1061; \n\nKrakow, D., Alanay, Y., Rimoin, L.P., Evaluation of prenatal-onset osteochondrodysplasias by ultrasonography: a retrospective and prospective analysis (2008) Am J Med Genet A, 146, p. 1917; \n\nHurst, J.A., Firth, H.V., Smithson, S., Skeletal dysplasias (2005) Semin Fetal Neonatal Med, 10, p. 233; \n\nFrancomano, C., Muenke, M., Craniosynostosis syndromes and skeletal dysplasias caused by mutations in fibroblast growth factor receptor genes (2002), In: Royce P, Steinmann B, eds. Connective tissue and its heritable disorders. New York:Wiley-LissTavormina, P.L., Shiang, R., Thompson, L.M., Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3 (1995) Nat Genet, 9, p. 321; \n\nByers, P., Cole, W., Osteogenesis imperfecta (2002), p. 385. , In: Royce P, Steinmann B, eds. Connective tissue and its heritable disorders. New York:Wiley-LissMorello, R., Bertin, T.K., Chen, Y., CRTAP is required for prolyl 3-hydroxylation and mutations cause recessive osteogenesis imperfecta (2006) Cell, 127, p. 291; \n\nCabral, W.A., Chang, W., Barnes, A.M., Prolyl 3-hydroxylase 1 deficiency causes a recessive metabolic bone disorder resembling lethal/severe osteogenesis imperfecta (2007) Nat Genet, 39, p. 359; \n\nBarnes, A.M., Chang, W., Morello, R., Deficiency of cartilage-associated protein in recessive lethal osteogenesis imperfecta (2006) N Engl J Med, 355, p. 2757; \n\nHorton, W., Hecht, J., Chondrodysplasias: disorders of cartilage matrix proteins (2002), In: Royce P, Steinmann B, eds. Connective tissue and its heritable disorders. New York:Wiley-LissNishimura, G., Haga, N., Kitoh, H., The phenotypic spectrum of COL2A1 mutations (2005) Hum Mutat, 26, p. 36; \n\nSpranger, J., Winterpacht, A., Zabel, B., The type II collagenopathies: a spectrum of chondrodysplasias (1994) Eur J Pediatr, 153, p. 56; \n\nZankl, A., Neumann, L., Ignatius, J., Dominant negative mutations in the C-propeptide of COL2A1 cause platyspondylic lethal skeletal dysplasia, torrance type, and define a novel subfamily within the type 2 collagenopathies (2005) Am J Med Genet A, 133, p. 61; \n\nCohen-solal, L., Zolezzi, F., Pignatti, P.F., Intrafamilial variable expressivity of osteogenesis imperfecta due to mosaicism for a lethal G382R substitution in the COL1A1 gene (1996) Mol Cell Probes, 10, p. 219; \n\nCohn, D.H., Starman, B.J., Blumberg, B., Recurrence of lethal osteogenesis imperfecta due to parental mosaicism for a dominant mutation in a human type I collagen gene (COL1A1) (1990) Am J Hum Genet, 46, p. 591; \n\nFerguson, H.L., Deere, M., Evans, R., Mosaicism in pseudoachondroplasia (1997) Am J Med Genet, 70, p. 287; \n\nForzano, F., Lituania, M., Viassolo, A., A familial case of achondrogenesis type II caused by a dominant COL2A1 mutation and \" patchy\" expression in the mosaic father (2007) Am J Med Genet A, 143, p. 2815. , Forzano F, Lituania M, Viassolo A; \n\nRaghunath, M., Mackay, K., Dalgleish, R., Genetic counselling on brittle grounds: recurring osteogenesis imperfecta due to parental mosaicism for a dominant mutation (1995) Eur J Pediatr, 154, p. 123; \n\nSobetzko, D., Braga, S., Rudeberg, A., Achondroplasia with the FGFR3 1138g-> a (G380R) mutation in two sibs sharing a 4p haplotype derived from their unaffected father (2000) J Med Genet, 37, p. 958; \n\nSuperti-furga, A., Unger, S., Nosology and classification of genetic skeletal disorders: 2006 revision (2007) Am J Med Genet A, 143, p. 1; \n\nUnger, S., Superti-furga, A., Rimoin, D., A diagnostic approach to skeletal dysplasias (2003), p. 375. , In: Glorieux FH, Juppner H, eds. Pediatric bone disease. Amsterdam: ElsevierUnger, S., A genetic approach to the diagnosis of skeletal dysplasia (2003) Clin Orthop Relat Res, 401, p. 32; \n\nRimoin, D., Lachman, R.S., Genetic disorders of the osseous skeleton (1993), p. 557. , In: Beighton P, ed. McKusick's heritable disorders of connective tissue. St Louis, MO:MosbyHorton, W., Hecht, J., Chondrodysplasias: general concepts and diagnostic and management considerations (2002), p. 901. , In: Royce P, Steinmann B, eds. Connective tissue and its heritable disorders. New York:Wiley-LissSuperti-furga, A., Bonafe, L., Rimoin, D.L., Molecular-pathogenetic classification of genetic disorders of the skeleton (2001) Am J Med Genet, 106, p. 282; \n\nCheung, M.S., Glorieux, F.H., Osteogenesis Imperfecta: update on presentation and management (2008) Rev Endocr Metab Disord, 9, p. 153; \n\nChu, M.-L., Prockop, D., Collagen: gene structure (2002), p. 223. , In: Royce P, Steinmann B, eds. Connective tissue and its heritable disorders. New York:Wiley-LissLund, A.M., Nicholls, A.C., Schwartz, M., Parental mosaicism and autosomal dominant mutations causing structural abnormalities of collagen I are frequent in families with osteogenesis imperfecta type III/IV (1997) Acta Paediatr, 86, p. 711; \n\nRaghunath, M., Steinmann, B., Delozier-blanchet, C., Prenatal diagnosis of collagen disorders by direct biochemical analysis of chorionic villus biopsies (1994) Pediatr Res, 36, p. 441; \n\nHa-vinh, R., Alanay, Y., Bank, R.A., Phenotypic and molecular characterization of Bruck syndrome (osteogenesis imperfecta with contractures of the large joints) caused by a recessive mutation in PLOD2 (2004) Am J Med Genet A, 131, p. 115; \n\nSillence, D., Osteogenesis imperfecta: an expanding panorama of variants (1981) Clin Orthop Relat Res, 159, p. 11; \n\nKorkko, J., Ala-kokko, L., de Paepe, A., Analysis of the COL1A1 and COL1A2 genes by PCR amplification and scanning by conformation-sensitive gel electrophoresis identifies only COL1A1 mutations in 15 patients with osteogenesis imperfecta type I: identification of common sequences of null-allele mutations (1998) Am J Hum Genet, 62, p. 98; \n\nGlorieux, F.H., Ward, L.M., Rauch, F., Osteogenesis imperfecta type VI: a form of brittle bone disease with a mineralization defect (2002) J Bone Miner Res, 17, p. 30; \n\nGlorieux, F.H., Rauch, F., Plotkin, H., Type V osteogenesis imperfecta: a new form of brittle bone disease (2000) J Bone Miner Res, 15, p. 1650; \n\nWard, L.M., Rauch, F., Travers, R., Osteogenesis imperfecta type VII: an autosomal recessive form of brittle bone disease (2002) Bone, 31, p. 12; \n\nLabuda, M., Morissette, J., Ward, L.M., Osteogenesis imperfecta type VII maps to the short arm of chromosome 3 (2002) Bone, 31, p. 19; \n\nWhyte, M.P., Osteopetrosis (2002), p. 789. , In: Royce P, Steinmann B, eds. Connective tissue and its heritable disorders. New York:Wiley-LissEl Khazen, N., Faverly, D., Vamos, E., Lethal osteopetrosis with multiple fractures in utero (1986) Am J Med Genet, 23, p. 811; \n\nVilla, A., Pangrazio, A., Caldana, E., Prognostic potential of precise molecular diagnosis of Autosomal Recessive Osteopetrosis with respect to the outcome of bone marrow transplantation (2008) Cytotechnology, 58, p. 57; \n\nFrattini, A., Orchard, P.J., Sobacchi, C., Defects in TCIRG1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosis (2000) Nat Genet, 25, p. 343; \n\nScimeca, J.C., Quincey, D., Parrinello, H., Novel mutations in the TCIRG1 gene encoding the a3 subunit of the vacuolar proton pump in patients affected by infantile malignant osteopetrosis (2003) Hum Mutat, 21, p. 151; \n\nSobacchi, C., Frattini, A., Orchard, P., The mutational spectrum of human malignant autosomal recessive osteopetrosis (2001) Hum Mol Genet, 10, p. 1767; \n\nKornak, U., Kasper, D., Bosl, M.R., Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man (2001) Cell, 104, p. 205; \n\nCampos-xavier, A.B., Saraiva, J.M., Ribeiro, L.M., Chloride channel 7 (CLCN7) gene mutations in intermediate autosomal recessive osteopetrosis (2003) Hum Genet, 112, p. 186; \n\nCleiren, E., Benichou, O., van Hul, E., Albers-Schonberg disease (autosomal dominant osteopetrosis, type II) results from mutations in the ClCN7 chloride channel gene (2001) Hum Mol Genet, 10, p. 2861; \n\nPangrazio, A., Poliani, P.L., Megarbane, A., Mutations in OSTM1 (grey lethal) define a particularly severe form of autosomal recessive osteopetrosis with neural involvement (2006) J Bone Miner Res, 21, p. 1098; \n\ndel Fattore, A., Fornari, R., van Wesenbeeck, L., A new heterozygous mutation (R714C) of the osteopetrosis gene, pleckstrin homolog domain containing family M (with run domain) member 1 (PLEKHM1), impairs vesicular acidification and increases TRACP secretion in osteoclasts (2008) J Bone Miner Res, 23, p. 380; \n\nvan Wesenbeeck, L., Odgren, P.R., Coxon, F.P., Involvement of PLEKHM1 in osteoclastic vesicular transport and osteopetrosis in incisors absent rats and humans (2007) J Clin Invest, 117, p. 919; \n\nSobacchi, C., Frattini, A., Guerrini, M.M., Osteoclast-poor human osteopetrosis due to mutations in the gene encoding RANKL (2007) Nat Genet, 39, p. 960; \n\nGuerrini, M.M., Sobacchi, C., Cassani, B., Human osteoclast-poor osteopetrosis with hypogammaglobulinemia due to TNFRSF11A (RANK) mutations (2008) Am J Hum Genet, 83, p. 64; \n\nShah, G.N., Bonapace, G., Hu, P.Y., Carbonic anhydrase II deficiency syndrome (osteopetrosis with renal tubular acidosis and brain calcification): novel mutations in CA2 identified by direct sequencing expand the opportunity for genotype-phenotype correlation (2004) Hum Mutat, 24, p. 272; \n\nSly, W.S., Whyte, M.P., Sundaram, V., Carbonic anhydrase II deficiency in 12 families with the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral calcification (1985) N Engl J Med, 313, p. 139; \n\nLee, B., Vissing, H., Ramirez, F., Identification of the molecular defect in a family with spondyloepiphyseal dysplasia (1989) Science, 244, p. 978; \n\nVissing, H., D'Alessio, M., Lee, B., Glycine to serine substitution in the triple helical domain of pro-alpha 1 (II) collagen results in a lethal perinatal form of short-limbed dwarfism (1989) J Biol Chem, 264, p. 18265; \n\nTiller, G.E., Polumbo, P.A., Weis, M.A., Dominant mutations in the type II collagen gene, COL2A1, produce spondyloepimetaphyseal dysplasia, Strudwick type (1995) Nat Genet, 11, p. 87; \n\nWalter, K., Tansek, M., Tobias, E.S., COL2A1-related skeletal dysplasias with predominant metaphyseal involvement (2007) Am J Med Genet A, 143, p. 161; \n\nWinterpacht, A., Hilbert, M., Schwarze, U., Kniest and Stickler dysplasia phenotypes caused by collagen type II gene (COL2A1) defect (1993) Nat Genet, 3, p. 323; \n\nAhmad, N.N., Ala-kokko, L., Knowlton, R.G., Stop codon in the procollagen II gene (COL2A1) in a family with the Stickler syndrome (arthro-ophthalmopathy) (1991) Proc Natl Acad Sci USA, 88, p. 6624; \n\nAnnunen, S., Korkko, J., Czarny, M., Splicing mutations of 54-bp exons in the COL11A1 gene cause Marshall syndrome, but other mutations cause overlapping Marshall/Stickler phenotypes (1999) Am J Hum Genet, 65, p. 974; \n\nFaber, J., Winterpacht, A., Zabel, B., Clinical variability of Stickler syndrome with a COL2A1 haploinsuffi-ciency mutation: implications for genetic counselling (2000) J Med Genet, 37, p. 318; \n\nRichards, A.J., Yates, J.R., Williams, R., A family with Stickler syndrome type 2 has a mutation in the COL11A1 gene resulting in the substitution of glycine 97 by valine in alpha 1 (XI) collagen (1996) Hum Mol Genet, 5, p. 1339; \n\nSirko-osadsa, D.A., Murray, M.A., Scott, J.A., Stickler syndrome without eye involvement is caused by mutations in COL11A2, the gene encoding the alpha2(XI) chain of type XI collagen (1998) J Pediatr, 132, p. 368; \n\nVikkula, M., Mariman, E.C., Lui, V.C., Autosomal dominant and recessive osteochondrodysplasias associated with the COL11A2 locus (1995) Cell, 80, p. 431; \n\nMelkoniemi, M., Brunner, H.G., Manouvrier, S., Autosomal recessive disorder otospondylomegaepiphyseal dysplasia is associated with loss-of-function mutations in the COL11A2 gene (2000) Am J Hum Genet, 66, p. 368; \n\nBateman, J.F., Wilson, R., Freddi, S., Mutations of COL10A1 in Schmid metaphyseal chondrodysplasia (2005) Hum Mutat, 25, p. 525; \n\nWarman, M.L., Abbott, M., Apte, S.S., A type X collagen mutation causes Schmid metaphyseal chondrodysplasia (1993) Nat Genet, 5, p. 79; \n\nMilunsky, J., Maher, T., Lebo, R., Prenatal diagnosis for Schmid metaphyseal chondrodysplasia in twins (1998) Fetal Diagn Ther, 13, p. 167; \n\nUnger, S., Bonafe, L., Superti-furga, A., Multiple epiphyseal dysplasia: clinical and radiographic features, differential diagnosis and molecular basis (2008) Best Pract Res Clin Rheumatol, 22, p. 19; \n\nChapman, K.L., Mortier, G.R., Chapman, K., Mutations in the region encoding the von Willebrand factor A domain of matrilin-3 are associated with multiple epiphyseal dysplasia (2001) Nat Genet, 28, p. 393; \n\nMakitie, O., Mortier, G.R., Czarny-ratajczak, M., Clinical and radiographic findings in multiple epiphyseal dysplasia caused by MATN3 mutations: description of 12 patients (2004) Am J Med Genet A, 125, p. 278; \n\nCzarny-ratajczak, M., Lohiniva, J., Rogala, P., A mutation in COL9A1 causes multiple epiphyseal dysplasia: further evidence for locus heterogeneity (2001) Am J Hum Genet, 69, p. 969; \n\nMuragaki, Y., Mariman, E.C., van Beersum, S.E., A mutation in the gene encoding the alpha 2 chain of the fibril-associated collagen IX, COL9A2, causes multiple epiphyseal dysplasia (EDM2) (1996) Nat Genet, 12, p. 103; \n\nPaassilta, P., Lohiniva, J., Annunen, S., COL9A3: a third locus for multiple epiphyseal dysplasia (1999) Am J Hum Genet, 64, p. 1036; \n\nBallhausen, D., Bonafe, L., Terhal, P., Recessive multiple epiphyseal dysplasia (rMED): phenotype delineation in eighteen homozygotes for DTDST mutation R279W (2003) J Med Genet, 40, p. 65; \n\nSuperti-furga, A., Neumann, L., Riebel, T., Recessively inherited multiple epiphyseal dysplasia with normal stature, club foot, and double layered patella caused by a DTDST mutation (1999) J Med Genet, 36, p. 621; \n\nBriggs, M.D., Chapman, K.L., Pseudoachondroplasia and multiple epiphyseal dysplasia: mutation review, molecular interactions, and genotype to phenotype correlations (2002) Hum Mutat, 19, p. 465; \n\nMcKeand, J., Rotta, J., Hecht, J.T., Natural history study of pseudoachondroplasia (1996) Am J Med Genet, 63, p. 406; \n\nIkegawa, S., Ohashi, H., Nishimura, G., Novel and recurrent COMP (cartilage oligomeric matrix protein) mutations in pseudoachondroplasia and multiple epiphyseal dysplasia (1998) Hum Genet, 103, p. 633; \n\nBonafe, L., Hastbacka, J., de la Chapelle, A., A novel mutation in the sulfate transporter gene SLC26A2 (DTDST) specific to the Finnish population causes de la Chapelle dysplasia (2008) J Med Genet, 45, p. 827; \n\nHastbacka, J., Kerrebrock, A., Mokkala, K., Identifi-cation of the Finnish founder mutation for diastrophic dysplasia (DTD) (1999) Eur J Hum Genet, 7, p. 664; \n\nHastbacka, J., Superti-furga, A., Wilcox, W.R., Atelosteogenesis type II is caused by mutations in the diastrophic dysplasia sulfate-transporter gene (DTDST): evidence for a phenotypic series involving three chondrodysplasias (1996) Am J Hum Genet, 58, p. 255; \n\nSuperti-furga, A., Skeletal dysplasias related to defects in sulfate metabolism (2002), p. 939. , In: Royce P, Steinmann B, eds. Connective tissue and its heritable disorders. New York:Wiley-LissRossi, A., Superti-furga, A., Mutations in the diastrophic dysplasia sulfate transporter (DTDST) gene (SLC26A2): 22 novel mutations, mutation review, associated skeletal phenotypes, and diagnostic relevance (2001) Hum Mutat, 17, p. 159; \n\nSuperti-furga, A., Hastbacka, J., Wilcox, W.R., Achondrogenesis type IB is caused by mutations in the diastrophic dysplasia sulphate transporter gene (1996) Nat Genet, 12, p. 100; \n\nSuperti-furga, A., Achondrogenesis type 1B (1996) J Med Genet, 33, p. 957; \n\nLarsen, L.J., Schottstaedt, E.R., Bost, F.C., Multiple congenital dislocations associated with characteristic facial abnormality (1950) J Pediatr, 37, p. 574; \n\nLatta, R.J., Graham, C.B., Aase, J., Larsen ' s syndrome: a skeletal dysplasia with multiple joint dislocations and unusual facies (1971) J Pediatr, 78, p. 291; \n\nKrakow, D., Robertson, S.P., King, L.M., Mutations in the gene encoding filamin B disrupt vertebral segmentation, joint formation and skeletogenesis (2004) Nat Genet, 36, p. 405; \n\nFarrington-rock, C., Firestein, M.H., Bicknell, L.S., Mutations in two regions of FLNB result in atelosteogenesis I and III (2006) Hum Mutat, 27, p. 705; \n\nHermanns, P., Unger, S., Rossi, A., Congenital joint dislocations caused by carbohydrate sulfotransferase 3 deficiency in recessive Larsen syndrome and humero-spinal dysostosis (2008) Am J Hum Genet, 82, p. 1368; \n\nFlores-sarnat, L., New insights into craniosynostosis (2002) Semin Pediatr Neurol, 9, p. 274; \n\nPassos-bueno, M.R., Serti Eacute, A.E., Jehee, F.S., Genetics of craniosynostosis: genes, syndromes, mutations and genotype-phenotype correlations (2008) Front Oral Biol, 12, p. 107; \n\nLievens, P.M., de Servi, B., Garofalo, S., Transient dimerization and interaction with ERGIC-53 occur in the fibroblast growth factor receptor 3 early secretory pathway (2008) Int J Biochem Cell Biol, 40, p. 2649; \n\nLievens, P.M., Liboi, E., The thanatophoric dysplasia type II mutation hampers complete maturation of fibroblast growth factor receptor 3 (FGFR3), which activates signal transducer and activator of transcription 1 (STAT1) from the endoplasmic reticulum (2003) J Biol Chem, 278, p. 17344; \n\nLievens, P.M., Roncador, A., Liboi, E., K644E/M FGFR3 mutants activate Erk1/2 from the endoplasmic reticulum through FRS2 alpha and PLC gamma-independent pathways (2006) J Mol Biol, 357, p. 783; \n\nHorton, W.A., Hall, J.G., Hecht, J.T., Achondroplasia (2007) Lancet, 370, p. 162; \n\nTrotter, T.L., Hall, J.G., Health supervision for children with achondroplasia (2005) Pediatrics, 116, p. 771; \n\nRousseau, F., Bonaventure, J., Legeai-mallet, L., Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia (1994) Nature, 371, p. 252; \n\nShiang, R., Thompson, L.M., Zhu, Y.Z., Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia (1994) Cell, 78, p. 335; \n\nIkegawa, S., Fukushima, Y., Isomura, M., Mutations of the fibroblast growth factor receptor-3 gene in one familial and six sporadic cases of achondroplasia in Japanese patients (1995) Hum Genet, 96, p. 309; \n\nSuperti-furga, A., Eich, G., Bucher, H.U., A glycine 375-to-cysteine substitution in the transmembrane domain of the fibroblast growth factor receptor-3 in a newborn with achondroplasia (1995) Eur J Pediatr, 154, p. 215; \n\nBellus, G.A., McIntosh, I., Smith, E.A., A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasia (1995) Nat Genet, 10, p. 357; \n\nBellus, G.A., Spector, E.B., Speiser, P.W., Distinct missense mutations of the FGFR3 lys650 codon modulate receptor kinase activation and the severity of the skeletal dysplasia phenotype (2000) Am J Hum Genet, 67, p. 1411; \n\nHeuertz, S., Le Merrer, M., Zabel, B., Novel FGFR3 mutations creating cysteine residues in the extracellular domain of the receptor cause achondroplasia or severe forms of hypochondroplasia (2006) Eur J Hum Genet, 14, p. 1240; \n\nMortier, G., Nuytinck, L., Craen, M., Clinical and radiographic features of a family with hypochondroplasia owing to a novel Asn540Ser mutation in the fibroblast growth factor receptor 3 gene (2000) J Med Genet, 37, p. 220; \n\nWinterpacht, A., Hilbert, K., Stelzer, C., A novel mutation in FGFR-3 disrupts a putative N-glycosylation site and results in hypochondroplasia (2000) Physiol Genomics, 2, p. 9; \n\nRousseau, F., Saugier, P., Le Merrer, M., Stop codon FGFR3 mutations in thanatophoric dwarfism type 1 (1995) Nat Genet, 10, p. 11; \n\nTavormina, P.L., Bellus, G.A., Webster, M.K., A novel skeletal dysplasia with developmental delay and acanthosis nigricans is caused by a Lys650Met mutation in the fibroblast growth factor receptor 3 gene (1999) Am J Hum Genet, 64, p. 722; \n\nCamera, G., Baldi, M., Strisciuglio, G., Occurrence of thanatophoric dysplasia type I (R248C) and hypochondroplasia (N540K) mutations in two patients with achondroplasia phenotype (2001) Am J Med Genet, 104, p. 2771; \n\nBaker, K.M., Olson, D.S., Harding, C.O., Long-term survival in typical thanatophoric dysplasia type 1 (1997) Am J Med Genet, 70, p. 427; \n\nTonoki, H., A boy with thanatophoric dysplasia surviving 212 days (1987) Clin Genet, 32, p. 415; \n\nKurtz, A.B., Filly, R.A., Wapner, R.J., In utero analysis of heterozygous achondroplasia: variable time of onset as detected by femur length measurements (1986) J Ultrasound Med, 5, p. 137; \n\nSukcharoen, N., Sonographic prenatal diagnosis of heterozygous achondroplasia: a case report (1994) J Med Assoc Thai, 77, p. 549; \n\nCordone, M., Lituania, M., Bocchino, G., Ultrasonographic features in a case of heterozygous achondroplasia at 25 weeks ' gestation (1993) Prenat Diagn, 13, p. 395; \n\nGuzman, E.R., Day-salvatore, D., Westover, T., Prenatal ultrasonographic demonstration of the trident hand in heterozygous achondroplasia (1994) J Ultrasound Med, 13, p. 63; \n\nLi, Y., Page-christiaens, G.C., Gille, J.J., Non-invasive prenatal detection of achondroplasia in size-fractionated cell-free DNA by MALDI-TOF MS assay (2007) Prenat Diagn, 27, p. 11; \n\nHuggins, M.J., Mernagh, J.R., Steele, L., Prenatal sonographic diagnosis of hypochondroplasia in a high-risk fetus (1999) Am J Med Genet, 87, p. 226; \n\nKaradimas, C., Sifakis, S., Valsamopoulos, P., Prenatal diagnosis of hypochondroplasia: report of two cases (2006) Am J Med Genet A, 140, p. 998; \n\nBellus, G.A., Escallon, C.S., Ortiz De Luna, R., First-trimester prenatal diagnosis in couple at risk for homozygous achondroplasia (1994) Lancet, 344, p. 1511; \n\nChitty, L.S., Tan, A.W., Nesbit, D.L., Sonographic diagnosis of SEDC and double heterozygote of SEDC and achondroplasia-a report of six pregnancies (2006) Prenat Diagn, 26, p. 861; \n\nFlynn, M.A., Pauli, R.M., Double heterozygosity in bone growth disorders: four new observations and review (2003) Am J Med Genet A, 121, p. 193; \n\nUnger, S., Korkko, J., Krakow, D., Double heterozygosity for pseudoachondroplasia and spondyloepiphyseal dysplasia congenita (2001) Am J Med Genet, 104, p. 140; \n\nGunthard, J., Fliegel, C., Ohnacker, H., Lung hypoplasia and severe pulmonary hypertension in an infant with double heterozygosity for spondyloepiphyseal dysplasia congenita and achondroplasia (1995) Clin Genet, 48, p. 35; \n\nWilkie, A.O., Craniosynostosis: genes and mechanisms (1997) Hum Mol Genet, 6, p. 1647; \n\nWilkie, A.O., Bad bones, absent smell, selfish testes: the pleiotropic consequences of human FGF receptor mutations (2005) Cytokine Growth Factor Rev, 16, p. 187; \n\nGlaser, R.L., Jiang, W., Boyadjiev, S.A., Paternal origin of FGFR2 mutations in sporadic cases of Crouzon syndrome and Pfeiffer syndrome (2000) Am J Hum Genet, 66, p. 768; \n\nGoriely, A., McVean, G.A., Rojmyr, M., Evidence for selective advantage of pathogenic FGFR2 mutations in the male germ line (2003) Science, 301, p. 643; \n\nMeyers, G.A., Day, D., Goldberg, R., FGFR2 exon IIIa and IIIc mutations in Crouzon, Jackson-Weiss, and Pfeiffer syndromes: evidence for missense changes, insertions, and a deletion due to alternative RNA splicing (1996) Am J Hum Genet, 58, p. 491; \n\nMuenke, M., Schell, U., Hehr, A., A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome (1994) Nat Genet, 8, p. 269; \n\nSchell, U., Hehr, A., Feldman, G.J., Mutations in FGFR1 and FGFR2 cause familial and sporadic Pfeiffer syndrome (1995) Hum Mol Genet, 4, p. 323; \n\nBellus, G.A., Gaudenz, K., Zackai, E.H., Identical mutations in three different fibroblast growth factor receptor genes in autosomal dominant craniosynostosis syndromes (1996) Nat Genet, 14, p. 174; \n\nMeyers, G.A., Orlow, S.J., Munro, I.R., Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans (1995) Nat Genet, 11, p. 462; \n\nOldridge, M., Zackai, E.H., McDonald-McGinn, D.M., De novo alu-element insertions in FGFR2 identify a distinct pathological basis for Apert syndrome (1999) Am J Hum Genet, 64, p. 446; \n\nWilkie, A.O., Slaney, S.F., Oldridge, M., Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome (1995) Nat Genet, 9, p. 165; \n\nMuenke, M., Gripp, K.W., McDonald-McGinn, D.M., A unique point mutation in the fibroblast growth factor receptor 3 gene (FGFR3) defines a new craniosynostosis syndrome (1997) Am J Hum Genet, 60, p. 555; \n\nJabs, E.W., Li, X., Scott, A.F., Jackson-Weiss and Crouzon syndromes are allelic with mutations in fibroblast growth factor receptor 2 (1994) Nat Genet, 8, p. 275; \n\nSteinmann, B., Royce, P., Superti-furga, A., The Ehlers-Danlos syndrome (2002), p. 431. , In: Royce P, Steinmann B, eds. Connective tissue and its heritable disorders. New York:Wiley-LissMalfait, F., Coucke, P., Symoens, S., The molecular basis of classic Ehlers-Danlos syndrome: a comprehensive study of biochemical and molecular findings in 48 unrelated patients (2005) Hum Mutat, 25, p. 28; \n\nMalfait, F., de Paepe, A., Molecular genetics in classic Ehlers-Danlos syndrome (2005) Am J Med Genet C Semin Med Genet, 139, p. 17; \n\nSchwarze, U., Atkinson, M., Hoffman, G.G., Null alleles of the COL5A1 gene of type V collagen are a cause of the classical forms of Ehlers-Danlos syndrome (types I and II) (2000) Am J Hum Genet, 66, p. 1757; \n\nLindor, N.M., Bristow, J., Tenascin-X deficiency in autosomal recessive Ehlers-Danlos syndrome (2005) Am J Med Genet A, 135, p. 75; \n\nSchalkwijk, J., Zweers, M.C., Steijlen, P.M., A recessive form of the Ehlers-Danlos syndrome caused by tenascin-X deficiency (2001) N Engl J Med, 345, p. 1167; \n\nPepin, M., Schwarze, U., Superti-furga, A., Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type (2000) N Engl J Med, 342, p. 673; \n\nSchwarze, U., Goldstein, J.A., Byers, P.H., Splicing defects in the COL3A1 gene: marked preference for 5 ′ (donor) spice-site mutations in patients with exon-skipping mutations and Ehlers-Danlos syndrome type IV (1997) Am J Hum Genet, 61, p. 1276; \n\nSchwarze, U., Schievink, W.I., Petty, E., Haploinsufficiency for one COL3A1 allele of type III procollagen results in a phenotype similar to the vascular form of Ehlers-Danlos syndrome, Ehlers-Danlos syndrome type IV (2001) Am J Hum Genet, 69, p. 989; \n\nSuperti-furga, A., Steinmann, B., Ramirez, F., Molecular defects of type III procollagen in Ehlers-Danlos syndrome type IV (1989) Hum Genet, 82, p. 104; \n\nYeowell, H.N., Walker, L.C., Mutations in the lysyl hydroxylase 1 gene that result in enzyme deficiency and the clinical phenotype of Ehlers-Danlos syndrome type VI (2000) Mol Genet Metab, 71, p. 212; \n\nKielty, C., Grant, M., The collagen family: structure, assembly, and organization in the extracellular matrix (2002), p. 159. , In: Royce P, Steinmann B, eds. Connective tissue and its heritable disorders. New York:Wiley-LissGiunta, C., Randolph, A., Steinmann, B., Mutation analysis of the PLOD1 gene: an efficient multistep approach to the molecular diagnosis of the kyphoscoliotic type of Ehlers-Danlos syndrome (EDS VIA) (2005) Mol Genet Metab, 86, p. 269; \n\nYeowell, H.N., Walker, L.C., Murad, S., A common duplication in the lysyl hydroxylase gene of patients with Ehlers Danlos syndrome type VI results in preferential stimulation of lysyl hydroxylase activity and mRNA by hydralazine (1997) Arch Biochem Biophys, 347, p. 126; \n\nEyre, D., Shao, P., Weis, M.A., The kyphoscoliotic type of Ehlers-Danlos syndrome (type VI): differential effects on the hydroxylation of lysine in collagens I and II revealed by analysis of cross-linked telopeptides from urine (2002) Mol Genet Metab, 76, p. 211; \n\nGiunta, C., Randolph, A., Al-gazali, L.I., Nevo syndrome is allelic to the kyphoscoliotic type of the Ehlers-Danlos syndrome (EDS VIA) (2005) Am J Med Genet A, 133, p. 158; \n\nByers, P.H., Duvic, M., Atkinson, M., Ehlers-Danlos syndrome type VIIA and VIIB result from splice-junction mutations or genomic deletions that involve exon 6 in the COL1A1 and COL1A2 genes of type I collagen (1997) Am J Med Genet, 72, p. 94; \n\nGiunta, C., Superti-furga, A., Spranger, S., Ehlers-Danlos syndrome type VII: clinical features and molecular defects (1999) J Bone Joint Surg Am, 81, p. 225; \n\nColige, A., Nuytinck, L., Hausser, I., Novel types of mutation responsible for the dermatosparactic type of Ehlers-Danlos syndrome (Type VIIC) and common polymorphisms in the ADAMTS2 gene (2004) J Invest Dermatol, 123, p. 656; \n\nColige, A., Sieron, A.L., Li, S.W., Human Ehlers-Danlos syndrome type VII C and bovine dermatosparaxis are caused by mutations in the procollagen I N-proteinase gene (1999) Am J Hum Genet, 65, p. 308; \n\nMalfait, F., de Coster, P., Hausser, I., The natural history, including orofacial features of three patients with Ehlers-Danlos syndrome, dermatosparaxis type (EDS type VIIC) (2004) Am J Med Genet A, 131, p. 18; \n\nFukada, T., Civic, N., Furuichi, T., The zinc transporter SLC39A13/ZIP13 is required for connective tissue development; its involvement in BMP/TGF-beta signaling pathways (2008) PLoS ONE, 3, pp. e3642; \n\nGiunta, C., Elcioglu, N.H., Albrecht, B., Spondylocheiro dysplastic form of the Ehlers-Danlos syndrome-an autosomal-recessive entity caused by mutations in the zinc transporter gene SLC39A13 (2008) Am J Hum Genet, 82, p. 1290; \n\nGu, Y.H., Kodama, H., Murata, Y., ATP7A gene mutations in 16 patients with Menkes disease and a patient with occipital horn syndrome (2001) Am J Med Genet, 99, p. 217; \n\nHorn, N., Tümer, Z., Menkes disease and the occipital horn syndrome (2002), p. 651. , In: Royce P, Steinmann B, eds. Connective tissue and its heritable disorders. New York:Wiley-LissLiu, P.C., McAndrew, P.E., Kaler, S.G., Rapid and robust screening of the Menkes disease/occipital horn syndrome gene (2002) Genet Test, 6, p. 255; \n\nMoller, L.B., Bukrinsky, J.T., Molgaard, A., Identification and analysis of 21 novel disease-causing amino acid substitutions in the conserved part of ATP7A (2005) Hum Mutat, 26, p. 84; \n\nHerman, T.E., McAlister, W.H., Boniface, A., Occipital horn syndrome (1992) Additional radiographic findings in two new cases. Pediatr Radiol, 22, p. 363; \n\nLazoff, S.G., Rybak, J.J., Parker, B.R., Skeletal dysplasia, occipital horns, diarrhea and obstructive uropathy-a new hereditary syndrome (1975) Birth Defects Orig Artic Ser, 11, p. 71; \n\nTsukahara, M., Imaizumi, K., Kawai, S., Occipital horn syndrome: report of a patient and review of the literature (1994) Clin Genet, 45, p. 32; \n\nBorm, B., Moller, L.B., Hausser, I., Variable clinical expression of an identical mutation in the ATP7A gene for Menkes disease/occipital horn syndrome in three affected males in a single family (2004) J Pediatr, 145, p. 119; \n\nKaler, S.G., Gallo, L.K., Proud, V.K., Occipital horn syndrome and a mild Menkes phenotype associated with splice site mutations at the MNK locus (1994) Nat Genet, 8, p. 195; \n\nMoller, L.B., Tumer, Z., Lund, C., Similar splice-site mutations of the ATP7A gene lead to different phenotypes: classical Menkes disease or occipital horn syndrome (2000) Am J Hum Genet, 66, p. 1211; \n\nGerard-blanluet, M., Birk-moller, L., Caubel, I., Early development of occipital horns in a classical Menkes patient (2004) Am J Med Genet A, 130, p. 211; \n\nProud, V.K., Mussell, H.G., Kaler, S.G., Distinctive Menkes disease variant with occipital horns: delineation of natural history and clinical phenotype (1996) Am J Med Genet, 65, p. 44; \n\nKaler, S.G., Holmes, C.S., Goldstein, D.S., Neonatal diagnosis and treatment of Menkes disease (2008) N Engl J Med, 358, p. 605; \n\nKaler, S.G., Tang, J., Donsante, A., Translational read-through of a nonsense mutation in ATP7A impacts treatment outcome in Menkes disease (2009) Ann Neurol, 65, p. 108; \n\nTang, J., Donsante, A., Desai, V., Clinical outcomes in Menkes disease patients with a copper-responsive ATP7A mutation, G727R (2008) Mol Genet Metab, 95, p. 174; \n\nPoulsen, L., Moller, L.B., Plunkett, K., X-linked Menkes disease: first documented report of germ-line mosaicism (2004) Genet Test, 8, p. 286; \n\nPyeritz, R., Dietz, H., Marfan syndrome and other microfibrillar disorders (2002), p. 585. , In: Royce P, Steinmann B, eds. Connective tissue and its heritable disorders. New York:Wiley-LissDean, J.C., Marfan syndrome: clinical diagnosis and management (2007) Eur J Hum Genet, 15, p. 724; \n\nGodfrey, M., Raghunath, M., Cisler, J., Abnormal morphology of fibrillin microfibrils in fibroblast cultures from patients with neonatal Marfan syndrome (1995) Am J Pathol, 146, p. 1414; \n\nRaghunath, M., Superti-furga, A., Godfrey, M., Decreased extracellular deposition of fibrillin and decorin in neonatal Marfan syndrome fibroblasts (1993) Hum Genet, 90, p. 511; \n\nSuperti-furga, A., Raghunath, M., Willems, P.J., Deficiencies of fibrillin and decorin in fibroblast cultures of a patient with neonatal Marfan syndrome (1992) J Med Genet, 29, p. 875; \n\nTekin, M., Cengiz, F.B., Ayberkin, E., Familial neonatal Marfan syndrome due to parental mosaicism of a missense mutation in the FBN1 gene (2007) Am J Med Genet A, 143, p. 875; \n\nMilewicz, D.M., Urban, Z., Boyd, C., Genetic disorders of the elastic fiber system (2000) Matrix Biol, 19, p. 471; \n\nRobinson, P.N., Booms, P., Katzke, S., Mutations of FBN1 and genotype-phenotype correlations in Marfan syndrome and related fibrillinopathies (2002) Hum Mutat, 20, p. 153; \n\nde Paepe, A., Devereux, R.B., Dietz, H.C., Revised diagnostic criteria for the Marfan syndrome (1996) Am J Med Genet, 62, p. 417; \n\nFaivre, L., Masurel-paulet, A., Collod-beroud, G., Clinical and molecular study of 320 children with Marfan syndrome and related type I fibrillinopathies in a series of 1009 probands with pathogenic FBN1 mutations (2009) Pediatrics, 123, p. 391; \n\nDietz, H.C., Cutting, G.R., Pyeritz, R.E., Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene (1991) Nature, 352, p. 337; \n\nKorkko, J., Kaitila, I., Lonnqvist, L., Sensitivity of conformation sensitive gel electrophoresis in detecting mutations in Marfan syndrome and related conditions (2002) J Med Genet, 39, p. 34; \n\nMizuguchi, T., Collod-beroud, G., Akiyama, T., Heterozygous TGFBR2 mutations in Marfan syndrome (2004) Nat Genet, 36, p. 855; \n\nLoeys, B.L., Chen, J., Neptune, E.R., A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2 (2005) Nat Genet, 37, p. 275; \n\nMizuguchi, T., Matsumoto, N., Recent progress in genetics of Marfan syndrome and Marfan-associated disorders (2007) J Hum Genet, 52, p. 1; \n\nRobinson, P.N., Arteaga-solis, E., Baldock, C., The molecular genetics of Marfan syndrome and related disorders (2006) J Med Genet, 43, p. 769; \n\nStheneur, C., Collod-beroud, G., Faivre, L., Identifi-cation of 23 TGFBR2 and 6 TGFBR1 gene mutations and genotype-phenotype investigations in 457 patients with Marfan syndrome type I and II, Loeys-Dietz syndrome and related disorders (2008) Hum Mutat, 29, pp. E 284; \n\nBrooke, B.S., Habashi, J.P., Judge, D.P., Angiotensin II blockade and aortic-root dilation in Marfan ' s syndrome (2008) N Engl J Med, 358, p. 2787; \n\nHabashi, J.P., Judge, D.P., Holm, T.M., Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome (2006) Science, 312, p. 117; \n\nLipscomb, K.J., Smith, J.C., Clarke, B., Outcome of pregnancy in women with Marfan ' s syndrome (1997) Br J Obstet Gynaecol, 104, p. 201; \n\nPacini, L., Digne, F., Boumendil, A., Maternal complication of pregnancy in Marfan syndrome (2008) Int J Cardiol, , ePub ahead of print; \n\nRamaswamy, P., Lytrivi, I.D., Nguyen, K., Neonatal Marfan syndrome: in utero presentation with aortic and pulmonary artery dilatation and successful repair of an acute flail mitral valve leaflet in infancy (2006) Pediatr Cardiol, 27, p. 763; \n\nStadie, R., Geipel, A., Heep, A., Prenatal diagnosis of Marfan syndrome (2007) Ultrasound Obstet Gynecol, 30, p. 119; \n\nViassolo, V., Lituania, M., Marasini, M., Fetal aortic root dilation: a prenatal feature of the Loeys-Dietz syndrome (2006) Prenat Diagn, 26, p. 1081; \n\nSkovby, F., Kraus, J., The homocystinurias (2002), p. 627. , In: Royce P, Steinmann B, eds. Connective tissue and its heritable disorders. New York:Wiley-LissCruysberg, J.R., Boers, G.H., Trijbels, J.M., Delay in diagnosis of homocystinuria: retrospective study of consecutive patients (1996) BMJ, 313, p. 1037; \n\nGaustadnes, M., Wilcken, B., Oliveriusova, J., The molecular basis of cystathionine beta-synthase defi-ciency in Australian patients: genotype-phenotype correlations and response to treatment (2002) Hum Mutat, 20, p. 117; \n\nMiles, E.W., Kraus, J.P., Cystathionine beta-synthase: structure, function, regulation, and location of homocystinuria-causing mutations (2004) J Biol Chem, 279, p. 29871; \n\nMoat, S.J., Bao, L., Fowler, B., The molecular basis of cystathionine beta-synthase (CBS) deficiency in UK and US patients with homocystinuria (2004) Hum Mutat, 23, p. 206; \n\nFowler, B., Jakobs, C., Post-and prenatal diagnostic methods for the homocystinurias (1998) Eur J Pediatr, 157, pp. S 88; \n\nNelder, K., Struck, B., Pseudoxanthoma elasticum (2002), p. 561. , In: Royce P, Steinmann B, eds. Connective tissue and its heritable disorders. New York:Wiley-LissOhtani, T., Furukawa, F., Pseudoxanthoma elasticum (2002) J Dermatol, 29, p. 615; \n\nChassaing, N., Martin, L., Calvas, P., Pseudoxanthoma elasticum: a clinical, pathophysiological and genetic update including 11 novel ABCC6 mutations (2005) J Med Genet, 42, p. 881; \n\nSakata, S., Su, J.C., Robertson, S., Varied presentations of pseudoxanthoma elasticum in a family (2006) J Paediatr Child Health, 42, p. 817; \n\nStruk, B., Cai, L., Zach, S., Mutations of the gene encoding the transmembrane transporter protein ABC-C6 cause pseudoxanthoma elasticum (2000) J Mol Med, 78, p. 282; \n\nLi, Q., Jiang, Q., Pfendner, E., Pseudoxanthoma elasticum: clinical phenotypes, molecular genetics and putative pathomechanisms (2009) Exp Dermatol, 18, p. 1; \n\nFulop, K., Barna, L., Symmons, O., Clustering of disease-causing mutations on the domain-domain interfaces of ABCC6 (2009) Biochem Biophys Res Commun, 379, p. 706; \n\nUitto, J., The gene family of ABC transporters-novel mutations, new phenotypes (2005) Trends Mol Med, 11, p. 341; \n\nChristen-zach, S., Huber, M., Struk, B., Pseudoxanthoma elasticum: evaluation of diagnostic criteria based on molecular data (2006) Br J Dermatol, 155, p. 89; \n\nUitto, J., Pseudoxanthoma elasticum-a connective tissue disease or a metabolic disorder at the genome/environment interface (2004) J Invest Dermatol, 122, pp. ix; \n\nJiang, Q., Endo, M., Dibra, F., Pseudoxanthoma elasticum is a metabolic disease (2009) J Invest Dermatol, 129, p. 348; \n\nRingpfeil, F., Lebwohl, M.G., Christiano, A.M., Pseudoxanthoma elasticum: mutations in the MRP6 gene encoding a transmembrane ATP-binding cassette (ABC) transporter (2000) Proc Natl Acad Sci USA, 97, p. 6001; \n\nMeloni, I., Rubegni, P., de Aloe, G., Pseudoxanthoma elasticum: point mutations in the ABCC6 gene and a large deletion including also ABCC1 and MYH11 (2001) Hum Mutat, 18, p. 85; \n\nLe Saux, O., Beck, K., Sachsinger, C., A spectrum of ABCC6 mutations is responsible for pseudoxanthoma elasticum (2001) Am J Hum Genet, 69, p. 749", "hasCitationDuplums" : false, "userChangeableUntil" : "2014-04-08T10:12:02.000+0000", "publishDate" : "2014-01-08T11:12:02.000+0000", "directInstitutesForSort" : "", "ownerAuthorCount" : 5, "ownerInstituteCount" : 27, "directInstituteCount" : 0, "authorCount" : 2, "contributorCount" : 0, "book" : { "otype" : "Book", "mtid" : 23291879, "link" : "/api/publication/23291879", "label" : "Milunsky A. Genetic Disorders and the Fetus: Diagnosis, Prevention and Treatment: Sixth Edition. (2010) ISBN:9781405190879", "core" : false, "citation" : true, "publicationPending" : false, "type" : { "otype" : "PublicationType", "mtid" : 23, "link" : "/api/publicationtype/23", "label" : "Könyv", "code" : 23, "otypeName" : "Book", "listPosition" : 3, "published" : true, "oldId" : 23, "snippet" : true }, "subType" : { "otype" : "SubType", "mtid" : 10000201, "link" : "/api/subtype/10000201", "label" : "Szakkönyv (Könyv)", "name" : "Szakkönyv", "nameEng" : "Monograph", "docType" : { "otype" : "PublicationType", "mtid" : 23, "link" : "/api/publicationtype/23", "label" : "Könyv", "code" : 23, "otypeName" : "Book", "listPosition" : 3, "published" : true, "oldId" : 23, "snippet" : true }, "listPosition" : 337, "published" : true, "oldId" : 10000201, "snippet" : true }, "category" : { "otype" : "Category", "mtid" : 1, "link" : "/api/category/1", "label" : "Tudományos", "published" : true, "oldId" : 1, "snippet" : true }, "languages" : [ { "otype" : "Language", "mtid" : 10002, "link" : "/api/language/10002", "label" : "Angol", "name" : "Angol", "nameEng" : "English", "published" : true, "oldId" : 2, "snippet" : true } ], "title" : "Genetic Disorders and the Fetus: Diagnosis, Prevention and Treatment: Sixth Edition", "identifiers" : [ { "otype" : "PublicationIdentifier", "mtid" : 6838851, "link" : "/api/publicationidentifier/6838851", "label" : "ISBN: 9781405190879", "source" : { "otype" : "PlainSource", "mtid" : 122, "link" : "/api/publicationsource/122", "label" : "ISBN", "type" : { "otype" : "PublicationSourceType", "mtid" : 10002, "link" : "/api/publicationsourcetype/10002", "label" : "Egyéb", "mayHaveOa" : false, "published" : true, "snippet" : true }, "name" : "ISBN", "nameEng" : "ISBN", "linkPattern" : "https://www.worldcat.org/search?q=isbn%3A@@@", "publiclyVisible" : true, "published" : true, "oldId" : 122, "snippet" : true }, "idValue" : "9781405190879", "realUrl" : "https://www.worldcat.org/search?q=isbn%3A9781405190879", "published" : false, "snippet" : true } ], "publishedAt" : [ { "otype" : "City", "mtid" : 16976, "link" : "/api/city/16976", "label" : "Baltimore, Amerikai Egyesült Államok", "deleted" : true, "partOf" : { "otype" : "Country", "mtid" : 10017, "link" : "/api/country/10017", "label" : "Amerikai Egyesült Államok", "published" : true, "oldId" : 13, "snippet" : true }, "duplumRole" : "DUPLUM_DELETED", "published" : true, "oldId" : 8, "snippet" : true } ], "publishedYear" : 2010, "foreignEdition" : true, "foreignLanguage" : true, "fullPublication" : true, "conferencePublication" : false, "nationalOrigin" : false, "published" : true, "oldId" : 13291879, "snippet" : true }, "hasQualityFactor" : false, "link" : "/api/publication/23547377", "label" : "Superti-Furga A et al. Prenatal Diagnosis of Disorders of Bone and Connective Tissue. (2010) Megjelent: Genetic Disorders and the Fetus: Diagnosis, Prevention and Treatment: Sixth Edition pp. 680-704", "template" : "